Skip to main content
Premium Trial:

Request an Annual Quote

IP Roundup: Panasonic, Agilent Technologies, Maxwell Sensors, Harvard University, and More

Premium

Panasonic of Osaka, Japan, has received US Patent No. 8,231,768, "Biosensor, biosensor chip and biosensor device." The described biosensor includes a working electrode, a counter electrode, and terminals attached to the respective electrodes by wires. According to the inventors, by employing a structure with at least three electrodes, it is possible to assay a target substance without being influenced by the line resistance on the working electrode side.


Agilent Technologies of Santa Clara, Calif., has received US Patent No. 8,232,055, "Comparative genomic hybridization assays using immobilized oligonucleotide features and compositions for practicing the same." The described comparative genomic hybridization assays rely on solid support immobilized oligonucleotide feature elements. Different nucleic acid populations are prepared from genomic templates and then contacted with distinct oligonucleotide feature elements immobilized on the solid support surface. The binding of the populations is then evaluated.


Maxwell Sensors of Santa Fe Springs, Calif., has received US Patent No. 8,232,092, "Apparatus and method for digital magnetic beads analysis." The patent describes assays that rely on microbeads that have digitally coded structures that are partially transmissive and opaque to light. According to the patent, the pattern of transmitted light can be determined to decode the bead. The coded beads may be coated or immobilized with a capture or probe to effect a desired bioassay and the beads can be deposited in microplate wells, allowing multiple-analyte tests to be performed in each well.


Harvard University of Cambridge, Mass., has received US Patent No. 8,232,584, "Nanoscale sensors." A nanoscale electrical sensor array device is described that includes an n-doped semiconductor nanoscale wire and a p-doped semiconductor nanoscale wire, each having a reaction entity immobilized on it. According to the patent, the binding of an analyte to the immobilized reaction entity causes a detectable change in the electrical property of the nanoscale wire.


Affymetrix has received US Patent No. 8,233,735, "Methods and apparatus for detection of fluorescently labeled materials." Following the methods described in the patent, fluorescently marked targets are bound to a substrate synthesized with polymer sequences at known locations. The targets are then detected by exposing selected regions of the substrate to light from a light source and detecting the photons from the light fluoresced. The steps of exposure and detection are repeated until the substrate is completely examined. The resulting data can be used to determine binding affinity of the targets to specific polymer sequences.


The Agency for Science, Technology and Research of Singapore has received US Patent No. 8,234,079, "Method and/or apparatus of oligonucleotide design and/or nucleic acid detection." The method includes identifying regions of a target nucleic acid to be amplified, where the regions have a higher than average efficiency of amplification; and designing oligonucleotides capable of hybridizing to the selected regions. According to the patent, the method can be used to detect the presence of a pathogen, for example a virus, in a human biological sample, and the probes may be placed on a support, such as a microarray.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.